Format

Send to

Choose Destination
Clin Infect Dis. 2006 Feb 15;42(4):507-15. Epub 2006 Jan 13.

Immunotherapy for fungal infections.

Author information

1
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. brahm.segal@roswellpark.org

Abstract

Opportunistic fungal infections are major causes of morbidity and mortality among immunocompromised individuals. Fungi have evolved complex and coordinated mechanisms to survive in the environment and in the mammalian host. Fungi must adapt to "stressors" in the host (including scarcity of nutrients, pH, and reactive oxygen and nitrogen intermediates) in addition to evading host immunity. Knowledge of the immunopathogenesis of fungal infections has paved the way to promising strategies for immunotherapy. These include strategies that increase phagocyte number, activate innate host defense pathways in phagocytes and dendritic cells, and stimulate antigen-specific immunity (e.g., vaccines). Immunotherapy must be tailored to specific immunocompromised states. Challenges exist in bringing promising immunotherapies from the laboratory to clinical trials.

PMID:
16421795
DOI:
10.1086/499811
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center